TR200101335T2 - İktidarsızlık tedavisi için pirazolopirimidinon türevleri - Google Patents

İktidarsızlık tedavisi için pirazolopirimidinon türevleri

Info

Publication number
TR200101335T2
TR200101335T2 TR2001/01335T TR200101335T TR200101335T2 TR 200101335 T2 TR200101335 T2 TR 200101335T2 TR 2001/01335 T TR2001/01335 T TR 2001/01335T TR 200101335 T TR200101335 T TR 200101335T TR 200101335 T2 TR200101335 T2 TR 200101335T2
Authority
TR
Turkey
Prior art keywords
derivatives
impotence
treatment
pirazolopyrimidinone
efficacy
Prior art date
Application number
TR2001/01335T
Other languages
English (en)
Inventor
Yoo Moohi
Kim Wonbae
Sun Chang Min
In Lim Joong
Sung Kim Dong
Yon Kim Ik
Kyun Lim Tae
Ok Ahn Byung
Koo Kang Kyung
Son Miwon
Doh Hyounmie
Kim Soonhoe
Shim Hyunjoo
Oh Taeyoung
Kim Heungjae
Goo Kim Dong
Original Assignee
Dong A Pharm. Co.,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27349839&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200101335(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dong A Pharm. Co.,Ltd. filed Critical Dong A Pharm. Co.,Ltd.
Publication of TR200101335T2 publication Critical patent/TR200101335T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Bu bulus, asagidaki Formül 1'in pirazolopirimindinon türevleriyle, bunlari hazirlama yöntemiyle ve söz konusu türevleri içeren farmasötik terkiplerle ilgilidir. Bilesimlerin,erkek cinsel islev bozukluklarindan biri olan iktidarsizligin, yan etkiler azaltilmis olarak tedavisinde etkisi vardir.
TR2001/01335T 1998-11-11 1999-11-10 İktidarsızlık tedavisi için pirazolopirimidinon türevleri TR200101335T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19980048100 1998-11-11
KR19990014972 1999-04-27
KR19990049384A KR100353014B1 (ko) 1998-11-11 1999-11-09 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물

Publications (1)

Publication Number Publication Date
TR200101335T2 true TR200101335T2 (tr) 2001-09-21

Family

ID=27349839

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01335T TR200101335T2 (tr) 1998-11-11 1999-11-10 İktidarsızlık tedavisi için pirazolopirimidinon türevleri

Country Status (17)

Country Link
US (1) US6583147B1 (tr)
EP (1) EP1129093B1 (tr)
JP (1) JP3577630B2 (tr)
KR (1) KR100353014B1 (tr)
CN (1) CN1136219C (tr)
AT (1) ATE245650T1 (tr)
AU (1) AU760422B2 (tr)
BR (1) BRPI9915822B8 (tr)
CA (1) CA2350538C (tr)
DE (1) DE69909818T2 (tr)
DK (1) DK1129093T3 (tr)
ES (1) ES2204169T3 (tr)
HK (1) HK1039328B (tr)
NZ (1) NZ511015A (tr)
PT (1) PT1129093E (tr)
TR (1) TR200101335T2 (tr)
WO (1) WO2000027848A1 (tr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000221A2 (en) * 1999-06-23 2001-01-04 Institut Pasteur Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
KR100377782B1 (ko) * 2000-06-23 2003-03-29 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논화합물의 제조방법
WO2003053975A1 (en) * 2001-12-13 2003-07-03 Daiichi Suntory Pharma Co., Ltd. Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
DE60332387D1 (de) 2002-12-13 2010-06-10 Warner Lambert Co Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege
WO2004082667A1 (en) * 2003-03-17 2004-09-30 Pfizer Products Inc. Treatment of type 1 diabetes with pde5 inhibitors
CN100374441C (zh) 2003-06-06 2008-03-12 天津倍方科技发展有限公司 二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其制药用途
JP2007518788A (ja) 2004-01-22 2007-07-12 ファイザー・インク バソプレッシンのアンタゴニスト活性を阻害するトリアゾール誘導体
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
KR20080016531A (ko) * 2005-02-18 2008-02-21 서피스 로직스, 인크. 약동학적으로 개선된 화합물
CA2598270A1 (en) * 2005-02-18 2006-08-24 Surface Logix, Inc. Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds
BRPI0610498A2 (pt) 2005-04-19 2010-06-22 Nycomed Gmbh uso de roflumilast,composição farmacêutica, produto de combinação e kit para o tratamento de hipertensão pulmonar
ATE537832T1 (de) * 2005-06-10 2012-01-15 Dong A Pharm Co Ltd Mittel zur prävention und behandlung von lebererkrankungen mit einem pyrazolopyrimidin- derivat
CN1966506A (zh) * 2005-11-17 2007-05-23 上海特化医药科技有限公司 吡唑并嘧啶酮衍生物及其制备方法和用途
AU2006341342B2 (en) * 2006-04-04 2010-05-20 Dong-A Pharmaceutical.Co., Ltd. Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound
EP2024369A4 (en) * 2006-06-05 2010-10-27 Matrix Lab Ltd NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE
AR062501A1 (es) 2006-08-29 2008-11-12 Actelion Pharmaceuticals Ltd Composiciones terapeuticas
UA100497C2 (ru) 2006-09-07 2013-01-10 Никомед Гмбх Комбинированное лечение сахарного диабета
US20090197899A1 (en) * 2006-10-20 2009-08-06 Concert Pharmaceuticals Inc. 3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide Derivatives and Methods of Use
WO2008070313A2 (en) * 2006-10-20 2008-06-12 Concert Pharmaceuticals Inc. 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
US20090270425A1 (en) * 2006-10-20 2009-10-29 Concert Pharmaceuticals Inc. 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
WO2008100886A1 (en) * 2007-02-12 2008-08-21 Auspex Pharmaceuticals, Inc. Preparation and use of deuterated udenafil analogues as highly selective pde5 modulators for the treatment of erectile dysfunction
EP2148692B1 (en) 2007-05-25 2017-01-25 Ipsen Pharma S.A.S. Melanocortin receptor ligands modified with hydantoin
KR101560844B1 (ko) 2007-06-04 2015-10-15 벤-구리온 유니버시티 오브 더 네게브 리서치 앤드 디벨럽먼트 어쏘러티 트라이-아릴계 화합물 및 이를 포함하는 조성물
KR101002490B1 (ko) * 2007-06-09 2010-12-17 동아제약주식회사 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
KR100920125B1 (ko) * 2007-10-02 2009-10-01 동아제약주식회사 양성 전립선 비대증 치료를 위한 피라졸로피리미디논화합물 및 알파 아드레날린성 수용체 길항제를 함유하는약제학적 배합물
RU2010115647A (ru) * 2007-10-02 2011-11-10 Донг-А Фарм.Ко., Лтд. (Kr) Композиция и способ лечения или профилактики доброкачественной гиперплазии предстательной железы и симптомов со стороны нижних отделов мочевыводящих путей
WO2009099620A1 (en) * 2008-02-04 2009-08-13 Concert Pharmaceuticals Inc. 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
KR20090087795A (ko) * 2008-02-13 2009-08-18 한양대학교 산학협력단 혈관 재협착 예방 및 치료를 위한 약학 조성물 및 이를포함하는 스텐트
KR101071877B1 (ko) * 2009-02-18 2011-10-10 동아제약주식회사 유데나필 산부가염, 그의 제조방법 및 이를 포함하는 약학적 조성물
GB0903493D0 (en) 2009-02-27 2009-04-08 Vantia Ltd New compounds
JP2013523809A (ja) 2010-04-05 2013-06-17 エスケー ケミカルズ カンパニー リミテッド Ｐｄｅ５抑制剤を含む皮膚しわ改善用組成物
CN102952138B (zh) 2011-08-17 2016-07-06 上海特化医药科技有限公司 一种吡唑并嘧啶酮化合物的盐、多晶型物及其药物组合物、制备方法和应用
IN2014MN01706A (tr) 2012-02-28 2015-05-29 Seoul Pharma Co Ltd
KR101953735B1 (ko) 2012-12-14 2019-03-04 한미약품 주식회사 포스포다이에스터라제-5 억제제를 포함하는 츄정
EA201690938A1 (ru) 2013-11-05 2016-11-30 Бен-Гурион Юниверсити Оф Дзе Негев Рисерч Энд Дивелопмент Оторити Соединения для лечения диабета и осложнений, возникающих из-за этого заболевания
AU2015302271B2 (en) 2014-08-12 2019-02-28 Children’s Hospital of Philadelphia Methods of improving myocardial performance in fontan patients using udenafil compositions
KR101645652B1 (ko) 2014-11-03 2016-08-08 (주)퓨젠바이오농업회사법인 세리포리아 락세라타에 의해 생산되는 세포외다당체를 유효성분으로 함유하는 성기능개선용 조성물
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法
KR102249155B1 (ko) * 2019-07-26 2021-05-07 주식회사 코아팜바이오 유데나필을 함유하는 약제학적 조성물
CN113493459B (zh) * 2020-04-07 2022-12-13 广州白云山医药集团股份有限公司白云山制药总厂 Pde5抑制剂化合物及其制备方法和应用
MX2023000150A (es) * 2020-06-19 2023-03-22 Anaxis Pharma Pty Ltd Compuesto de sulfonamida.
TW202237615A (zh) * 2020-12-11 2022-10-01 南韓商日東製藥股份有限公司 作為雄激素受體及磷酸二酯酶雙重抑制劑的新穎化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9119704D0 (en) * 1991-09-14 1991-10-30 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
SK285991B6 (sk) * 1997-04-25 2008-01-07 Pfizer Inc. Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze
KR100297814B1 (ko) * 1998-12-29 2001-10-26 조민호 피라졸로피리미디논유도체와이의제조방법그리고이의용도

Also Published As

Publication number Publication date
BRPI9915822B8 (pt) 2021-05-25
DE69909818T2 (de) 2004-05-27
CN1136219C (zh) 2004-01-28
HK1039328A1 (en) 2002-04-19
PT1129093E (pt) 2003-12-31
US6583147B1 (en) 2003-06-24
KR100353014B1 (ko) 2002-09-18
NZ511015A (en) 2003-09-26
BR9915822B1 (pt) 2013-08-27
CA2350538A1 (en) 2000-05-18
ES2204169T3 (es) 2004-04-16
DK1129093T3 (da) 2003-10-20
EP1129093A1 (en) 2001-09-05
ATE245650T1 (de) 2003-08-15
KR20000035324A (ko) 2000-06-26
WO2000027848A1 (en) 2000-05-18
CN1325398A (zh) 2001-12-05
EP1129093B1 (en) 2003-07-23
HK1039328B (zh) 2004-06-25
DE69909818D1 (de) 2003-08-28
AU760422B2 (en) 2003-05-15
AU1081700A (en) 2000-05-29
JP3577630B2 (ja) 2004-10-13
CA2350538C (en) 2005-06-28
JP2002529467A (ja) 2002-09-10
BR9915822A (pt) 2001-08-14

Similar Documents

Publication Publication Date Title
BR9915822A (pt) Derivados de pirazolopirimidinona para o tratamento de impotência
LU90856I2 (fr) Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
CA2343236A1 (en) 4,4-biarylpiperidine derivatives
YU21401A (sh) Tetrahidropiridoetri
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
PL367682A1 (en) Dolastatin 10 derivatives
BG103947A (en) Derivatives of 9-oxymerythromycin
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
CA2352505A1 (en) Epothilone derivatives and their use as antitumor agents
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
MXPA02009552A (es) Derivados de imidazopiridina alquilada.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
ATE238981T1 (de) Antitumorwirkstoffe
DK1109814T3 (da) 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion
ATE267816T1 (de) Tan-1057 derivate
IL151198A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
ATE397615T1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
BG105178A (bg) Нови 2,3,3а,4,9,9а-хексахидро-8-хидрокси-1н-бенз/f/индоли, метод за получаването им и приложението им като лекарствени средства
NO20010624D0 (no) N-substituerte azacykloheptanderivater, fremstilling og anvendelse derav
PE61999A1 (es) Compuestos de tetrahidropiridina